Outcomes for Patients with Relapsed and Refractory Peripheral T-Cell Lymphoma in the 21st Century By Relapse Status, Salvage Therapy, and Receipt of Allogeneic Transplant

Category Primary study
JournalBlood
Year 2022
This article has no abstract
Epistemonikos ID: 6779564d2bdff3d8d5d67ff4bf926a1f274c6203
First added on: Feb 16, 2025